<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-08</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-08</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>63</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
æ–‡ç« æ­ç¤ºäº†æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç»„å¦‚ä½•é€šè¿‡è¡¨è§‚é—ä¼ è°ƒæ§è‚ é“å¹²ç»†èƒï¼Œè®­ç»ƒå…ç–«è®°å¿†ï¼ˆGSE275418, GSE310995, GSE275219ï¼‰ã€‚æ­¤å¤–ï¼Œæ”¾ç–—ä¸AAVä»‹å¯¼çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œæœ‰æœ›é‡å¡‘è‚¿ç˜¤å±€éƒ¨åŠå…¨èº«æŠ—è‚¿ç˜¤å…ç–«ï¼ˆGSE280079, GSE280078, GSE280080ï¼‰ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚ é“å¾®ç”Ÿæ€ä¸å…ç–«</strong>ï¼šç ”ç©¶æ–­å¥¶è¿‡ç¨‹å¯¹è‚ é“å¾®ç”Ÿç‰©ç»„æˆã€è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ åŠå…ç–«è®°å¿†å½¢æˆçš„å½±å“ã€‚<br />
*   <strong>è‚¿ç˜¤å…ç–«ç–—æ³•</strong>ï¼šæ¢ç´¢æ”¾ç–—ä¸åŸºå› ç–—æ³•ï¼ˆAAVï¼‰è”åˆåœ¨è‚¿ç˜¤æ²»ç–—ä¸­çš„å…ç–«è°ƒæ§æœºåˆ¶ã€‚<br />
*   <strong>è¡¨è§‚é—ä¼ è°ƒæ§</strong>ï¼šæ·±å…¥è§£æTGF-Î²ã€LSD1ç­‰å…³é”®å› å­åœ¨å…ç–«è®­ç»ƒã€ç‚ç—‡åŠè‚¿ç˜¤å‘ç”Ÿå‘å±•ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§ä½œç”¨ã€‚<br />
*   <strong>å•ç»†èƒå¤šç»„å­¦</strong>ï¼šåˆ©ç”¨å•ç»†èƒRNA-seqã€scATAC-seqã€scMultiomeç­‰æŠ€æœ¯è§£æå¤æ‚ç–¾ç—…ï¼ˆå¦‚ç³–å°¿ç—…ã€æ·‹å·´ç˜¤ï¼‰åŠå‘è‚²è¿‡ç¨‹ä¸­çš„ç»†èƒå¼‚è´¨æ€§ä¸è°ƒæ§æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šç»„å­¦æ•´åˆåˆ†æ</strong>ï¼šé€šè¿‡å¤šç»´åº¦æ•°æ®ï¼ˆå¦‚RNA-seq, WGS, WGBS, scATAC-seq, scRNA-seq, Spatial Transcriptomicsï¼‰æ­ç¤ºç”Ÿç‰©å­¦è¿‡ç¨‹çš„æ·±å±‚æœºåˆ¶ã€‚<br />
*   <strong>æ–°å‹åŸºå› ç¼–è¾‘ä¸é€’é€æŠ€æœ¯</strong>ï¼šå¦‚AAV-basedå…ç–«ç–—æ³•ï¼Œä»¥åŠç”¨äºé¶å‘åŸºå› è°ƒæ§çš„CreERç³»ç»Ÿã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç ”ç©¶å‘ç°CCL3è¡¨è¾¾çš„ä¿ƒè‚¿ç˜¤ä¸­æ€§ç²’ç»†èƒçŠ¶æ€ï¼Œé¦–æ¬¡æ­ç¤ºå…¶åœ¨è·¨è‚¿ç˜¤ç±»å‹å’Œç‰©ç§ä¸­é¢„æµ‹ä¸è‰¯é¢„åçš„æ™®éæœºåˆ¶ï¼›æ–°å‹RNAæµ‹åºæŠ€æœ¯å®ç°å¯¹å¤šç§RNAä¿®é¥°çš„ç›´æ¥æ£€æµ‹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è¯†åˆ«é¢„æµ‹ç™Œç—‡é¢„åçš„å…ç–«ç»†èƒçŠ¶æ€ï¼ˆå¦‚CCL3é«˜è¡¨è¾¾ä¸­æ€§ç²’ç»†èƒï¼‰<br />
- é˜æ˜ç»“ç›´è‚ ç™Œå…ç–«æŠ‘åˆ¶æœºåˆ¶ï¼ˆTregç»†èƒçš„ä½œç”¨ï¼‰<br />
- RNAä¿®é¥°çš„ç›´æ¥æ£€æµ‹ä¸è¡¨è§‚è½¬å½•ç»„åˆ†æ</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åŸºäºRNAæµ‹åºçš„ä¿ƒè‚¿ç˜¤ä¸­æ€§ç²’ç»†èƒçŠ¶æ€é‰´å®š<br />
- å•ä¸€ä¿®é¥°æ„ŸçŸ¥ç¢±åŸºè¯†åˆ«æ¨¡å‹ï¼Œç›´æ¥ä»çº³ç±³å­”æ•°æ®è¯»å–RNAä¿®é¥°</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (60æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE275418 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿†ï¼ˆRNA-seqï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€gutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDuring weaning, the transition to solid food diversifies the gut microbiome, triggering a programmed immune response critical for long-lasting mucosal immunity. Previous work showed that the gut microbiome mediates epigenetic development in intestinal stem cells (ISCs) during suckling, but what happens during weaning is unclear. Here, using genome-wide methylation profiling revealed that weaning-driven microbiome changes shape the DNA methylome and transcriptome of murine ISCs in an IFN-g dependent manner. Specifically, we observe demethylation of enhancer elements essential for MHC class II genes, which result in a transcriptional memory that persists through differentiation into adulthood. IFN-g blockade, or low-dose penicillin to target Gram-positive bacteria, in early life impaired microbiome-mediated epigenetic control and mucosal immunity, and exacerbated colitis. Murine organoids primed with IFN-g showed rapid, amplified transcriptional responses upon secondary stimulations. These findings reveal that early-life events alter the gut microbiome and these changes reprogram ISC epigenetic memory to shape mucosal immunity.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275418" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE316301 è‚¿ç˜¤åŸºè´¨è›‹ç™½èšç³–çš„ç§¯ç´¯å’ŒåŠ å·¥æ”¹å˜äº†å¯¡è½¬ç§»æ€§ç»“ç›´è‚ ç™Œä¸­Tç»†èƒçš„æ•ˆåº”åŠŸèƒ½å’Œå¯¹å…ç–«ç–—æ³•çš„ååº”</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€T cellã€regex:immuno(logy|therapy|suppression)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dustin Deming ; Sean Krau ; Joshua Brand ; Katherine Johnson ; Daniel Abbott ; Jeremy Kratz ; Anita Turk ; Philip Emmeric ; Evie Carchman ; Sam Lubner ; Noelle LoConte ; Anita Turk ; Nataliya Uboha ; Somak Chaudhuri ; Ruchi Shah ; Anna Field ; Elizabeth Field ; Cheri Pasch ; David Kim ; Sharon Weber ; Charles Heise ; Elise Lawson ; Cristina Sanger ; Kristina Matkowskyj ; Fotis Asimakopoulos ; Jens Eickhoff ; Huy Dinh ; Michael BassettiSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensVersican (VCAN) is an immunoregulatory extracellular matrix proteoglycan that when cleaved by ADAMTS proteases releases an immunostimulatory fragment, versikine. Here, we confirm that VCAN accumulates within colorectal cancers (CRCs) and inhibits T cell trafficking/effector function. VCAN is heavily proteolyzed in a subset of CRCs (VCAN proteolytic predominant (VPP)), leading to enhanced T cell infiltration. This phenotype was found to be more common in oligometastatic CRCs. A phase 1b clinical trial examined the safety/efficacy of the sequential combination of stereotactic body radiotherapy and pembrolizumab in patients undergoing resection of their microsatellite stable oligometastatic CRCs. The primary endpoint was met with a 1-year recurrence free survival (RFS) of 60%. Of those enrolled, 40% of cancers had the VPP phenotype, which was associated with improved RFS and overall survival. The VPP phenotype was associated with improved circulating T cell effector function, which was enhanced with study treatment. Clinical trial information: NCT02837263.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316301" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE280079 æ”¾å°„ç–—æ³•ä¸åŸºäº AAV çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–« [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€regex:immuno(logy|therapy|suppression)ã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Juan Dubrot ; JesÃºs Prieto ; Elizabeth Guruceaga ; Sonia MarcoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRadiotherapy (RT) primes the immune system against cancer antigens but fails to trigger effective antitumor responses due to concomitant induction of immunosuppressive factors. To expand the benefits of RT, we combine local radiation with immuno-gene therapy by harnessing the ability of ionizing radiation to enhance AAV-mediated tumor transduction. To successfully deliver AAV-based local immunotherapy and restrict transgene expression within tumors, we designed a recombinant AAV that expresses IL-12 through an interferon (IFN)-inducible promoter (AAV-iIL12). Local administration of AAV-iIL12 upon RT results in marked and durable elevation of intratumor IL-12 with minor and transient systemic release. This strategy generates a highly immunostimulatory tumor microenvironment (TME) leading to strong antitumor responses in an IFNg-dependent manner. Moreover, local treatment with RT and AAV-iIL12 elicits systemic antitumor immunity with marked CD8+ T cell infiltration and regression of distant tumors. Our work shows that radiation coupled with AAV-based immuno-gene delivery is a novel, efficient and safe approach that can be exploited as cancer therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280079" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE280078 æ”¾å°„ç–—æ³•ä¸åŸºäº AAV çš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–« [scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€regex:immuno(logy|therapy|suppression)ã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Juan Dubrot ; JesÃºs Prieto ; Elizabeth Guruceaga ; Seth Anderson ; Sonia MarcoSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusRadiotherapy (RT) primes the immune system against cancer antigens but fails to trigger effective antitumor responses due to concomitant induction of immunosuppressive factors. To expand the benefits of RT, we combine local radiation with immuno-gene therapy by harnessing the ability of ionizing radiation to enhance AAV-mediated tumor transduction. To successfully deliver AAV-based local immunotherapy and restrict transgene expression within tumors, we designed a recombinant AAV that expresses IL-12 through an interferon (IFN)-inducible promoter (AAV-iIL12). Local administration of AAV-iIL12 upon RT results in marked and durable elevation of intratumor IL-12 with minor and transient systemic release. This strategy generates a highly immunostimulatory tumor microenvironment (TME) leading to strong antitumor responses in an IFNg-dependent manner. Moreover, local treatment with RT and AAV-iIL12 elicits systemic antitumor immunity with marked CD8+ T cell infiltration and regression of distant tumors. Our work shows that radiation coupled with AAV-based immuno-gene delivery is a novel, efficient and safe approach that can be exploited as cancer therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280078" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE279313 TGF-Î² æ§åˆ¶ IFN æŠ—ç—…æ¯’è®­ç»ƒå…ç–«çš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹å¹¶æŸå®³ SIV æ„ŸæŸ“æ’æ²³çŒ´çš„ç—…æ¯’æ§åˆ¶ [bulk RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmunityã€RNA-seqã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Felipe ten-Caten ; Khader Ghneim ; Mirko Paiardini ; Susan P Ribeiro ; Rafick P SekalySeries Type : Expression profiling by high throughput sequencingOrganism : Macaca mulattaCurrent immunotherapeutic approaches to eliminate latently HIV-infected cells have focused on targeting the adaptive arm of the immune system using vaccines and passive transfer of broadly neutralizing antibodies (bNAbs). Epigenetic reprogramming of innate myeloid cells triggered by adjuvants was recently shown to promote a state of interferon (IFN)-induced antiviral immunity and resistance to heterologous viral infections. Herein, flow cytometry, bulk and single-cell RNA-Seq/ATAC-Seq were performed on samples from a cohort of SIV-infected, virologically suppressed rhesus macaques (RMs) treated with anti-IL-10 and anti-PD-1 monoclonal antibodies (combo treatment) prior to analytical treatment interruption (ATI). These experiments revealed that combo treatment led to selective changes in chromatin accessibility, expression of IRF7/3 and STAT1, and expression of IFN-stimulated antiviral genes in myeloid cells and CD4+ T cells. These RMs showed a stringent and prolonged control of SIV viral rebound following ATI and a decay in levels of cell-associated viral DNA (CA-vDNA) in lymph nodes. These RMs showed reduced chromatin accessibility for the SMAD2/SMAD3, AP-1, and NFKB1 loci and lower expression of TGF-b and SMADs target genes. This signature is consistent with that observed in HIV elite controllers, who maintain undetectable levels of virus in the absence of ART and whose HIV reservoir size is small. These results highlight the critical role of the interplay between TGF-b and IFN in epigenetically regulated innate antiviral immune responses that can impact the viral reservoir.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279313" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE314342 äººç±»åŸä»£ CD4+ T ç»†èƒçš„åŸºå› ç»„è§„æ¨¡æ‰°åŠ¨æµ‹åºæ­ç¤ºäº†è°ƒæ§ T ç»†èƒç¨‹åºå’Œäººç±»å…ç–«ç‰¹å¾çš„åŸºå› ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Ronghui Zhu ; Emma Dann ; Jun Yan ; Justine Reyes Retana ; Ryunosuke Goto ; Reese C Guitche ; Lillian K Petersen ; Mineto Ota ; Brian R Shy ; Jonathan K Pritchard ; Alexander MarsonSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCD4+ T cells orchestrate immune responses against infection and cancer, yet a comprehensive map of their gene regulatory networks has been lacking. Perturb-seq enables systematic mapping of such networks, but large-scale application in primary human T cells has been challenging. Here, we developed a scalable, probe-based Perturb-seq platform and performed genome-scale perturbations of all expressed genes across 22 million primary CD4+ T cells from four donors under three stimulation conditions. We demonstrate the utility of this dataset in three ways. First, we identify previously unrecognized regulators of the two important immune cytokines, IL-10 and IL-21. Second, we show that ex vivo perturbation signatures can model T cell states observed in population-scale atlases, revealing regulators of helper T cell polarization and T cell aging. Third, we leverage regulatory relationships to mechanistically explain geneâ€“trait associations in immune-related diseases, nominating genes for uncharacterized immune functions. Thus genome-scale perturb-seq in primary human T cells provides a foundational resource for decoding immune variation in humans and reprogramming T cell states for next-generation precision therapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314342" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE310995 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿†ï¼ˆå…¨åŸºå› ç»„æµ‹åºï¼‰</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : OtherOrganism : Mus musculusDuring weaning, the shift from milk to solid food is accompanied by a rapid expansion and diversification of the gut microbiome. This triggers the weaning reaction, a programmed immune response important for long-lasting mucosal immunity that is poorly understood. Here, we characterize the impact of the gut microbiome on the DNA methylome and transcriptome of intestinal stem cells (ISCs) from weaning to young adulthood in mice. We identify a weaning- IFN-g-TET3 axis that reprograms epithelial MHC-II signaling via enhancer demethylation in ISCs, establishing a lasting transcriptional memory into adulthood. Disruption of this axis by IFN-g blockade or low-dose penicillin attenuates the microbiota-mediated epigenetic control of epithelial MHC-II signaling, leading to impaired mucosal immunity. By engaging immune crosstalk and metabolite production, the weaning microbiome drives epigenetic reprogramming, thereby establishing a microbiome-induced regulatory pathway that couples developmental cues to lifelong epithelial immune resilience.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310995" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE275219 æ–­å¥¶é©±åŠ¨çš„è‚ é“å¾®ç”Ÿç‰©ç¾¤å¡‘é€ è‚ é“å¹²ç»†èƒè¡¨è§‚é—ä¼ å­¦ä»¥è®­ç»ƒå…ç–«è®°å¿† (WGBS)</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?ã€regex:intestin(e|al)<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Li Yang ; Lanlan ShenSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusDuring weaning, the transition from milk to solid food rapidly expands and diversifies the gut microbiome, triggering the weaning reaction, a programmed immune response critical for long-lasting mucosal immunity. We characterized how these microbiome changes from weaning through young adulthood in mice shape the DNA methylome and transcriptome of intestinal stem cells (ISCs). We identified a weaning-induced IFN-gâ€“TET3 axis as a key driver of MHC class II enhancer-linked epigenetic reprogramming, creating a transcriptional memory that persists through differentiation into adulthood. Early-life disruption of this axis, via IFN-g blockade or low-dose penicillin, impaired microbiota-mediated epigenetic control and mucosal immunity. Weaning-associated microbiome shifts enriched metabolites such as Î±-ketoglutarate, Fe2+, and methionine g-lyase, promoting TET-dependent DNA demethylation. These findings reveal how early-life events imprint lifelong epigenetic regulation of mucosal immunity, highlighting epithelial cells as innate immune sentinels that acquire trained transcriptional memory in response to microbial cues.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE275219" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE318371 æ–°è¯Šæ–­çš„NK/Tç»†èƒæ·‹å·´ç˜¤æ‚£è€…å¤–å‘¨è¡€å•æ ¸ç»†èƒå•ç»†èƒå›¾è°±</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šlymphomaã€T cellã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaozhen Liang ; Rong Tao ; Ran Jia ; Chuanxu LiuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensNatural killer/T cell lymphoma (NKTCL) is a rare and aggressive form of non-Hodgkin's lymphoma associated with Epstein-Barr Virus (EBV) infection.The recent advancement of multi-omics technologies has significantly enhanced our understanding of NKTCL disease biology, including genetics, transcription landscape, variations of EBV strain, and microenvironments. Emerging evidence suggests that immunoprofiling of peripheral blood mononuclear cells (PBMCs) is associated with the treatment response of cancer patients and can be used to guide clinical trials and therapy. In this study, we utilized single-cell RNA sequencing (scRNA-seq) to comprehensively characterize the phenotypic landscape of PBMCs in newly diagnosed patients with NKTCL. This research offers a valuable peripheral blood-based signature for newly diagnosed NKTCL, which could be a crucial resource for further investigations into the pathogenesis of NKTCL and the optimization of therapeutic regimens.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318371" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE317297 åµå·¢ç‚ç—‡è¡°è€çš„å¤šç»†èƒèµ·æº [ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Anna Galligos ; Joseph Varberg ; Wei-Ting Yueh ; Aubrey Converse ; Seth Malloy ; Fatimah Aljubran ; Francesca E Duncan ; Jennifer L GertonSeries Type : OtherOrganism : Mus musculusAge-dependent reproductive decline has become a significant global health concern as the average maternal age at first birth increases. Fertility loss associated with reproductive aging is driven in part by alterations to ovarian composition and function, dysregulation of folliculogenesis and increased inflammatory signaling. Our understanding of the molecular changes underlying ovarian aging has been expanded by single cell and spatial transcriptomic studies, which identified infiltration of immune cells as a feature of ovarian aging. However, the function of these age-associated immune cells and their potential contributions to the inflammaging phenotype remains unclear. In this study we integrate single cell and spatial transcriptomics to define changes in the composition and intercellular signaling in the aging mouse ovary. We identify specific macrophage and T cell subpopulations that increase with age and are key sources of pro-inflammatory signaling in old ovaries. Further, we predict bidirectional signaling between these pro-inflammatory cells and granulosa cell populations that may impair follicular growth and development while promoting immune cell recruitment. These findings provide new insights into the mechanisms that drive ovarian inflammaging.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317297" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 50 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>ä¸€ç§å…ç–«å˜é‡å¯ä»¥é¢„æµ‹ä¸åŒè‚¿ç˜¤ç±»å‹å’Œç‰©ç§çš„ä¸è‰¯é¢„åã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing, researchers identify a conserved pro-tumor neutrophil state marked by CCL3 expression, revealing how specific immune cell programs support cancer growth across tumor types...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/one-immune-variable-predicts-poor-outcomes-across-tumor-types-and-species/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>ä¸ºä»€ä¹ˆç»“ç›´è‚ ç™Œä¼šæ‰“ç ´å…ç–«ç³»ç»Ÿçš„è§„åˆ™</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šColorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells arenâ€™t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these â€œgoodâ€ and â€œbadâ€ cells can determine whether a tumor grows or shrinks.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/02/260206012229.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>åˆ©ç”¨çº³ç±³å­”æµ‹åºç›´æ¥è¯»å–RNAä¿®é¥°</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šNew RNA sequencing tools enable direct detection of multiple RNA modifications from nanopore data, simplifying epitranscriptome analysis with a single modification-aware basecalling model...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/reading-rna-modifications-directly-with-nanopore-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>immunity</td>
<td>13</td>
</tr>
<tr>
<td>tumor</td>
<td>12</td>
</tr>
<tr>
<td>single-cell</td>
<td>7</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>7</td>
</tr>
<tr>
<td>immune</td>
<td>6</td>
</tr>
<tr>
<td>cancer</td>
<td>6</td>
</tr>
<tr>
<td>scRNA</td>
<td>5</td>
</tr>
<tr>
<td>regex:immuno(logy</td>
<td>therapy</td>
</tr>
<tr>
<td>regex:intestin(e</td>
<td>al)</td>
</tr>
<tr>
<td>sequencing</td>
<td>3</td>
</tr>
<tr>
<td>T cell</td>
<td>3</td>
</tr>
<tr>
<td>gut</td>
<td>3</td>
</tr>
<tr>
<td>regex:gut(-?microbiome)?</td>
<td>3</td>
</tr>
<tr>
<td>methylation</td>
<td>2</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>2</td>
</tr>
<tr>
<td>epigenetic</td>
<td>2</td>
</tr>
<tr>
<td>transcriptome</td>
<td>2</td>
</tr>
<tr>
<td>RNAseq</td>
<td>2</td>
</tr>
<tr>
<td>inflammation</td>
<td>2</td>
</tr>
<tr>
<td>spatial</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (50æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318384" target="_blank" rel="noopener noreferrer">GSE318384 æ•´åˆå¤šç»„å­¦åˆ†ææ­ç¤º METTL3 è¿‡è¡¨è¾¾åœ¨ A549 è‚ºç™Œç»†èƒä¸­å¼•èµ·çš„æŠ‘ç™Œè¡¨å‹åŠç›¸å…³è½¬å½•ç»„é‡å¡‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298505" target="_blank" rel="noopener noreferrer">GSE298505 è›‹ç™½æ¿€é…¶ CK2Î±â€™ ä½œä¸º Tau è›‹ç™½ç—…ä¸­å…ç–«ä¿¡å·ä¼ å¯¼å’Œçªè§¦åŠŸèƒ½éšœç¢çš„åŒé‡è°ƒèŠ‚å› å­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294115" target="_blank" rel="noopener noreferrer">GSE294115 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿå˜åŒ– [scATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294114" target="_blank" rel="noopener noreferrer">GSE294114 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿå˜åŒ– [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282071" target="_blank" rel="noopener noreferrer">GSE282071 æ‹Ÿå—èŠ¥ ROS1 åœ¨è°ƒèŠ‚æŸ“è‰²è´¨å¯åŠæ€§å’Œ DNA ç”²åŸºåŒ–ä¸­çš„å¤šç§ä½œç”¨ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280080" target="_blank" rel="noopener noreferrer">GSE280080 æ”¾å°„ç–—æ³•ä¸åŸºäºAAVçš„å…ç–«ç–—æ³•ååŒä½œç”¨ï¼Œå¯è¯±å¯¼å±€éƒ¨å’Œå…¨èº«æŠ—è‚¿ç˜¤å…ç–«ååº”ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279314" target="_blank" rel="noopener noreferrer">GSE279314 TGF-Î² æ§åˆ¶ IFN æŠ—ç—…æ¯’è®­ç»ƒå…ç–«çš„è¡¨è§‚é—ä¼ é‡ç¼–ç¨‹ï¼Œå¹¶æŸå®³ SIV æ„ŸæŸ“æ’æ²³çŒ´çš„ç—…æ¯’æ§åˆ¶ [scMultiome]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318611" target="_blank" rel="noopener noreferrer">GSE318611 æœè‡é»‘è…¹æœè‡å—…è§‰æŠ•å°„ç¥ç»å…ƒåœ¨è›¹å½¢æˆå 12 å°æ—¶ (h APF) çš„å•ç»†èƒè½¬å½•ç»„è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302760" target="_blank" rel="noopener noreferrer">GSE302760 æŠ‘åˆ¶LSD1å¯è§£é”ç±»è§†é»„é†‡AP-1ç¨‹åºï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302485" target="_blank" rel="noopener noreferrer">GSE302485 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [RNAseq_LSD1iRARi]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302483" target="_blank" rel="noopener noreferrer">GSE302483 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CutRun_LSD1i48h]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302480" target="_blank" rel="noopener noreferrer">GSE302480 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CreERTRNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302477" target="_blank" rel="noopener noreferrer">GSE302477 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [CreERTCutRun]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302474" target="_blank" rel="noopener noreferrer">GSE302474 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium CreERT]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302473" target="_blank" rel="noopener noreferrer">GSE302473 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium è‚¿ç˜¤]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302470" target="_blank" rel="noopener noreferrer">GSE302470 æŠ‘åˆ¶ LSD1 å¯è§£é”ç±»è§†é»„é†‡ AP-1 ç¼–ç¨‹ï¼Œä»è€Œæ¿€æ´»ä¸Šçš®å…ç–«å’Œçš®è‚¤è‚¿ç˜¤æŠ‘åˆ¶ [Xenium èƒšèƒ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299107" target="_blank" rel="noopener noreferrer">GSE299107 ç‚ç—‡æ€§ epiCaspase-1 é€šè¿‡è¿œç¨‹åå‘éª¨é«“é€ è¡€æ¥æŠ‘åˆ¶å…ç–«åŸæ€§ç»†èƒæ­»äº¡ï¼Œä»è€Œé©±åŠ¨ä»¥ä¸­æ€§ç²’ç»†èƒä¸ºä¸»çš„å…¨èº«æ€§ç‚ç—‡ [T24 RNAseq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317789" target="_blank" rel="noopener noreferrer">GSE317789 å•ç»†èƒå’Œç©ºé—´åˆ†ææ­ç¤ºäº†çš®è‚¤å’Œé»è†œæ‰å¹³è‹”è—“ä¸­ cDC2A-CXCL13+ CD8+ T ä¸Šçš®ç»†èƒé€šè¿‡ TNFRSF9 è¿›è¡Œä¸²æ‰°å’Œç»†èƒæ¯’æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318649" target="_blank" rel="noopener noreferrer">GSE318649 è½½ä½“å’Œè°·æ°¨é…¸ç¡¼é…¸å¤„ç†å°é¼ è„¾è„å…ç–«ç»†èƒçš„å•ç»†èƒRNAæµ‹åºæ•°æ®[é‡å¤å®éªŒ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289185" target="_blank" rel="noopener noreferrer">GSE289185 æ–°è¾…åŠ©æ”¾ç–—å’Œå…ç–«ç–—æ³•æ²»ç–—é£Ÿç®¡é³çŠ¶ç»†èƒç™Œçš„å®‰å…¨æ€§å’Œæœ‰æ•ˆæ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294237" target="_blank" rel="noopener noreferrer">GSE294237 å•ç»†èƒå¤šæ¨¡æ€åˆ†ææ­ç¤ºç³–å°¿ç—…å°é¼ å°½ç®¡è¡€ç³–æ§åˆ¶è‰¯å¥½ï¼Œä¸»åŠ¨è„‰å¹³æ»‘è‚Œç»†èƒä»æŒç»­å‘ç”Ÿæ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291420" target="_blank" rel="noopener noreferrer">GSE291420 è§£è¯»å°é¼ å„å™¨å®˜è¡°è€çš„è½¬å½•ç»„ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289338" target="_blank" rel="noopener noreferrer">GSE289338 RNA-Seq åˆ†æäººè¶³ç»†èƒä¸­ ATOH8 æ•²ä½</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282075" target="_blank" rel="noopener noreferrer">GSE282075 ROS1ï¼šæ‹Ÿå—èŠ¥ä¸­å¯åŠæŸ“è‰²è´¨çš„å…³é”®æ ‡è®°å’Œè°ƒèŠ‚å› å­ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282073" target="_blank" rel="noopener noreferrer">GSE282073 æ‹Ÿå—èŠ¥ ROS1 åœ¨è°ƒèŠ‚æŸ“è‰²è´¨å¯åŠæ€§å’Œ DNA ç”²åŸºåŒ–ä¸­çš„å¤šç§ä½œç”¨ [äºšç¡«é…¸æ°¢ç›æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282072" target="_blank" rel="noopener noreferrer">GSE282072 ROS1: Key Marker and Regulator of Accessible Chromatin in Arabidopsis [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281781" target="_blank" rel="noopener noreferrer">GSE281781 MYC ä¸æ–°ç”Ÿ RNA çš„ç»“åˆé€šè¿‡ R ç¯è¡ç”Ÿçš„ RNA-DNA æ‚äº¤ä½“æŠ‘åˆ¶å…ˆå¤©å…ç–«ä¿¡å·ä¼ å¯¼</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259427" target="_blank" rel="noopener noreferrer">GSE259427 miR-203 æ§åˆ¶æ¤å…¥å‰èƒšèƒå‘ç”Ÿè¿‡ç¨‹ä¸­çš„å‘è‚²æ—¶åºå’Œæ—©æœŸå‘½è¿é™åˆ¶ï¼ˆscRNA-Seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259426" target="_blank" rel="noopener noreferrer">GSE259426 miR-203 æ§åˆ¶æ¤å…¥å‰èƒšèƒå‘ç”Ÿè¿‡ç¨‹ä¸­çš„å‘è‚²æ—¶åºå’Œæ—©æœŸå‘½è¿é™åˆ¶ï¼ˆRNA-Seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317412" target="_blank" rel="noopener noreferrer">GSE317412 è†³é£Ÿè°·æ°¨é…°èƒºè¡¥å……å‰‚é€šè¿‡é™åˆ¶ H3K27me3 æ¥ç¼“è§£ä¸å¹´é¾„ç›¸å…³çš„å¿ƒè„è¡°é€€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313923" target="_blank" rel="noopener noreferrer">GSE313923 é¶å‘æ·‹å·´ç®¡å¯é€šè¿‡å¢å¼ºå°é¼ æˆªè‚¢æ¨¡å‹ä¸­çš„ç ´éª¨ç»†èƒæ´»æ€§æ¥ä¿ƒè¿›éª¨å†ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307297" target="_blank" rel="noopener noreferrer">GSE307297 ç±»é£æ¹¿æ€§å…³èŠ‚ç‚ç›¸å…³é—´è´¨æ€§è‚ºç–¾ç—…çš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305629" target="_blank" rel="noopener noreferrer">GSE305629 è‚Œå±‚æµ¸æ¶¦æ€§è†€èƒ±ç™Œ (MIBC) ä¸­çš„ä¸­æ€§ç²’ç»†èƒå’Œ CD8+ T ç»†èƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304377" target="_blank" rel="noopener noreferrer">GSE304377 è¥å…»åŸºå› ç»„å­¦æ­ç¤ºç»´ç”Ÿç´  B3 ç–—æ³•å¯æ²»æ„ˆ NAXD ç–¾ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303721" target="_blank" rel="noopener noreferrer">GSE303721 è‚¾ç™Œä¸­SOCS3â€“JAK1â€“STAT3è½´ä»‹å¯¼çš„HIF-2Î±å¢å¼ºå­è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298565" target="_blank" rel="noopener noreferrer">GSE298565 ä½¿ç”¨ PATTY æ ¡æ­£æ‰¹é‡å’Œå•ç»†èƒ CUT&amp;Tag æ•°æ®ä¸­çš„å¼€æ”¾æŸ“è‰²è´¨åå€š [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298319" target="_blank" rel="noopener noreferrer">GSE298319 ç‚ç—‡æ€§è¡¨è§‚Caspase-1é€šè¿‡è¿œç¨‹è°ƒæ§éª¨é«“é€ è¡€ï¼Œé©±åŠ¨ä»¥ä¸­æ€§ç²’ç»†èƒä¸ºä¸»çš„å…¨èº«æ€§ç‚ç—‡ï¼Œä»è€ŒæŠ‘åˆ¶å…ç–«åŸæ€§ç»†èƒæ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314609" target="_blank" rel="noopener noreferrer">GSE314609 é…®ä½“Î²-ç¾ŸåŸºä¸é…¸é€šè¿‡éä»£è°¢ä¾èµ–æ€§æœºåˆ¶æ¢å¤Tauè›‹ç™½ç¨³æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311934" target="_blank" rel="noopener noreferrer">GSE311934 åº”æ¿€è¯±å¯¼çš„ ADGRL4 é€šè¿‡ GÎ±s-YAP1 ä¿¡å·é€šè·¯å’Œè¡€ç®¡ç”Ÿæˆè°ƒæ§è‚¿ç˜¤ä¼‘çœ å’Œå¤å‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299422" target="_blank" rel="noopener noreferrer">GSE299422 å¯¹å…±åŸ¹å…»çš„ç™Œç»†èƒ-å®¿ä¸»ç»†èƒè¿›è¡Œè½¬å½•ç»„åˆ†æï¼Œå‘ç°ç¼ºæ°§æ˜¯éª¨éª¼è‚Œç»†èƒæŠ‘åˆ¶ç™Œç»†èƒå¢æ®–ä½œç”¨çš„é©±åŠ¨å› ç´ ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296363" target="_blank" rel="noopener noreferrer">GSE296363ï¼šå¯¹å•ä¸ªåµæ¯ç»†èƒè¿›è¡Œå°RNAå’Œé•¿RNAçš„æ•´åˆæµ‹åºæ­ç¤ºäº†äººç±»åµå­å‘ç”Ÿè¿‡ç¨‹ä¸­piRNAä»‹å¯¼çš„è½¬åº§å­æŠ‘åˆ¶ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289182" target="_blank" rel="noopener noreferrer">GSE289182 è¡¨è§‚è½¬å½•ç»„åˆ†ææ­ç¤ºäº†ä¸¤ç§è¥¿ç“œæ„ŸæŸ“çš„RNAç—…æ¯’ä¸­ä¸å­˜åœ¨m6Aä¿®é¥°</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318449" target="_blank" rel="noopener noreferrer">GSE318449 Wnt7a-Hoxa13é€šè·¯åœ¨å­å®«å½¢æ€å‘ç”Ÿè¿‡ç¨‹ä¸­ä¿ƒè¿›ä½“ä¸­çº¿è‹—å‹’æ°ç®¡èåˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318448" target="_blank" rel="noopener noreferrer">GSE318448 è¯ç†å­¦æ–¹æ³•æé«˜ä¹³é…¸æ°´å¹³å¯é€šè¿‡ç»„è›‹ç™½ä¹³åŒ–è¯±å¯¼çš„IL-10äº§ç”Ÿç¼“è§£è„“æ¯’ç—‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289127" target="_blank" rel="noopener noreferrer">GSE289127 é‡‘å¤´é²·è‚ é“çš„å®æ—¶å®šé‡PCRåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286304" target="_blank" rel="noopener noreferrer">GSE286304 ä¹™é…¸ç›å¯ä¿ƒè¿›çº¢é…µæ¯èŒï¼ˆRhodotorula toruloidesï¼‰çš„æœ¨ç³–ä»£è°¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268657" target="_blank" rel="noopener noreferrer">GSE268657 Isl1CKOå°é¼ æ¨¡å‹å†…åˆ†æ³Œèƒ°è…ºè°±ç³»çš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE252636" target="_blank" rel="noopener noreferrer">GSE252636 å°é¼ è„¾è„æ¥æºçš„å¹¼ç¨šTç»†èƒã€ä¸­å¤®è®°å¿†Tç»†èƒå’Œæ•ˆåº”è®°å¿†Tç»†èƒçš„RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224872" target="_blank" rel="noopener noreferrer">GSE224872 ATAC-seq æ•°æ®æ¥è‡ªåœ¨ OVA257-264 åˆºæ¿€ä¸‹ä¸è½½ä½“æˆ– TAMos å…±åŸ¹å…»çš„ OT-I ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE224871" target="_blank" rel="noopener noreferrer">GSE224871 RNA-seq åˆ†æäº†åœ¨ OVA257-264 åˆºæ¿€ä¸‹ï¼Œä¸è½½ä½“ã€TANs æˆ– TAMos å…±åŸ¹å…»çš„ OT-I ç»†èƒã€‚</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-07 21:46</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>